Title: Brexit – Preparing for the end of the transition period and beyond
Duration: 60 minutes - Available On Demand
PharmaLex experts will provide updates for our UK, EU and international audiences answering queries on the most recent updates and final preparations for the end of the Brexit transition period. Following recent intense negotiations, the EMA and MHRA have recently published revised guidance setting out their position on preparing for the end of the transition period.
We have analyzed the impact for the Pharmaceutical industry and have prepared this webinar to discuss the next steps for:
- Import-export and Wholesale distribution.
- The revised Regulatory framework and associated timelines.
- How Pharmacovigilance safety information and ICSRs will be handled.
Head of Medical Affairs, PharmaLex
Associate Director, Regulatory Affairs, PharmaLex
Director QMC, PharmaLex